[Recurrent hypertrophic pyloric stenosis - diagnostics and treatment]

Khirurgiia
|April 19, 2018
PubMed

Insights

Recurrent hypertrophic pyloric stenosis (HPS) is a serious complication of pyloromyotomy. Insufficient surgical technique is a leading cause, emphasizing the need for surgeon competence in treating this common infant condition.

Area of Science:

  • Pediatric Surgery
  • Gastrointestinal Surgery

Background:

  • Hypertrophic pyloric stenosis (HPS) is the most frequent surgically managed cause of infant vomiting.
  • Pyloromyotomy accounts for approximately 30% of infant surgeries.

Purpose of the Study:

  • To analyze the incidence and management of recurrent hypertrophic pyloric stenosis (HPS) after initial pyloromyotomy.
  • To identify factors contributing to recurrent HPS.

Main Methods:

  • Retrospective review of 154 pediatric patients with HPS operated between 2000 and 2015.
  • Analysis of four cases (2.6%) requiring reoperation for recurrent HPS.

Main Results:

  • Four patients (2.6%) underwent reoperation for recurrent HPS within 3 to 12 days post-initial surgery.
  • Three of these cases were referred from other facilities, with one initial pyloromyotomy performed by a general surgeon.
  • Reoperations included one Heineke-Mikulicz pyloroplasty and three new pyloromyotomies at different sites.

Conclusions:

  • Recurrent HPS is a significant complication of pyloromyotomy.
  • Inadequate surgical technique is a primary driver of recurrent HPS, underscoring the critical importance of surgeon expertise.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
282
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
526
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
744
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
312
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
294
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
600